Top Midday Decliners

In This Article:

Ironwood Pharmaceuticals (IRWD) said Monday that a confirmatory phase 3 trial is needed to seek appr

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.